- Home
- IMCC vs NCNA Comparison
IMCC vs NCNA Comparison
Compare IMCC & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- NCNA
- Stock Information
- Founded
- IMCC 1980
- NCNA 1997
- Country
- IMCC Israel
- NCNA United Kingdom
- Employees
- IMCC N/A
- NCNA N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- NCNA Health Care
- Exchange
- IMCC Nasdaq
- NCNA Nasdaq
- Market Cap
- IMCC 5.0M
- NCNA 4.4M
- IPO Year
- IMCC N/A
- NCNA 2017
- Fundamental
- Price
- IMCC $2.81
- NCNA $1.49
- Analyst Decision
- IMCC
- NCNA Buy
- Analyst Count
- IMCC 0
- NCNA 2
- Target Price
- IMCC N/A
- NCNA $25.00
- AVG Volume (30 Days)
- IMCC 27.2K
- NCNA 138.4K
- Earning Date
- IMCC 11-14-2024
- NCNA 11-26-2024
- Dividend Yield
- IMCC N/A
- NCNA N/A
- EPS Growth
- IMCC N/A
- NCNA N/A
- EPS
- IMCC N/A
- NCNA N/A
- Revenue
- IMCC $38,042,859.00
- NCNA N/A
- Revenue This Year
- IMCC $22.59
- NCNA N/A
- Revenue Next Year
- IMCC $20.53
- NCNA N/A
- P/E Ratio
- IMCC N/A
- NCNA N/A
- Revenue Growth
- IMCC N/A
- NCNA N/A
- 52 Week Low
- IMCC $1.13
- NCNA $1.49
- 52 Week High
- IMCC $8.10
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- IMCC 71.25
- NCNA 34.09
- Support Level
- IMCC $1.84
- NCNA $1.53
- Resistance Level
- IMCC $3.34
- NCNA $1.66
- Average True Range (ATR)
- IMCC 0.26
- NCNA 0.09
- MACD
- IMCC 0.10
- NCNA 0.05
- Stochastic Oscillator
- IMCC 64.78
- NCNA -3.70
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.